Non-inferiority versus superiority drug claims: the (not so) subtle distinction

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Non-inferiority versus superiority drug claims: the (not so) subtle distinction

BACKGROUND Current regulatory guidance and practice of non-inferiority trials are asymmetric in favor of the test treatment (Test) over the reference treatment (Control). These trials are designed to compare the relative efficacy of Test to Control by reference to a clinically important margin, M. MAIN TEXT Non-inferiority trials allow for the conclusion of: (a) non-inferiority of Test to Con...

متن کامل

Superiority, equivalence, and non-inferiority trials.

When the aim of the randomized controlled trial (RCT) is to show that one treatment is superior to another, a statistical test is employed and the trial (test) is called a superiority trial (test). Often a nonsignificant superiority test is wrongly interpreted as proof of no difference between the two treatments. Proving that two treatments are equal in performance is impossible with statistica...

متن کامل

Methodology of superiority vs. equivalence trials and non-inferiority trials.

The randomized clinical trial (RCT) is generally accepted as the best method of comparing effects of therapies. Most often the aim of an RCT is to show that a new therapy is superior to an established therapy or placebo, i.e. they are planned and performed as superiority trials. Sometimes the aim of an RCT is just to show that a new therapy is not superior but equivalent to or not inferior to a...

متن کامل

The Not-So-Subtle body in Dais’ Birth Imagery

This paper explores the notions of the subtle body and how it has given shape and life to birth rituals and notions in the Dai tradition.

متن کامل

Phase IV non-inferiority trials and additional claims of benefit

BACKGROUND Non-inferiority (NI) trials in drug research are used to demonstrate that a new treatment is not less effective than an active comparator. Since phase IV trials typically aim at informing a clinical decision, the value of a phase IV non-inferiority trial hinges also on its clinical relevance. In such trials, clinical relevance would refer to the added benefit claims of a specific dru...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Trials

سال: 2017

ISSN: 1745-6215

DOI: 10.1186/s13063-017-2024-2